中财网 中财网股票行情
荣昌生物(688331)财务分析指标    年份：
截止日期2026-09-302026-06-302026-03-312025-12-312025-09-30
营业总收入(万元)676378.14585329.3765621.44325105.11171983.30
营业收入(万元)676378.14585329.3765621.44325105.11171983.30
营业总成本(万元)235701.78152163.5169687.88319171.66227206.07
营业成本(万元)40919.6925093.3011695.6541354.0527059.34
净利润(万元)525705.61465432.8632833.8076230.19-50110.77
归属于母公司的净利润(万元)527323.11466228.3432800.7170964.98-55070.06
营业利润(万元)528619.04466866.2433017.0372260.59-53726.92
利润总额(万元)527382.26466287.4732849.3671039.85-55070.06
少数股东损益(万元)----------
基本每股收益(元)9.41(元)8.32(元)0.58(元)1.29(元)-1.01(元)
稀释每股收益(元)9.37(元)8.29(元)0.58(元)1.29(元)-1.01(元)
非经常性损益(万元)---------545.63
扣除非经常性损益后净利润(万元)441204.31433835.13-3499.106767.55-54524.42
总资产(万元)1054634.17984724.99736519.39724807.23597712.99
总负债(万元)165359.50153317.48343672.93363925.06365704.68
归属于母公司股东权益合计(万元)889274.68831407.51392846.47360882.17232008.31
股东权益合计(万元)889274.68831407.51392846.47360882.17232008.31
实收资本(股本)(万元)56447.7556447.7556447.7556371.0256360.82
资本公积(万元)696431.42695529.52696506.86692379.66692375.71
未分配利润(万元)170526.48109431.71-323995.92-360671.59-487257.18
经营活动产生的现金流量净额(万元)408369.44421382.291131.805295.1921705.74
经营活动现金流入小计(万元)655629.95580895.7977060.84271924.14225593.59
经营活动现金流出小计(万元)247260.51159513.4975929.04266628.95203887.84
投资活动产生的现金流量净额(万元)-247937.61-202551.222057.98-20564.79-27954.57
投资活动现金流入小计(万元)288736.61185950.8166455.34216495.91106279.49
投资活动现金流出小计(万元)536674.22388502.0464397.35237060.70134234.06
筹资活动产生的现金流量净额(万元)-180188.15-180226.06-8253.2655195.8337096.87
筹资活动现金流入小计(万元)44379.4035909.2219119.03284972.49211727.13
筹资活动现金流出小计(万元)224567.55216135.2827372.29229776.66174630.25
期末现金及现金等价物余额(万元)94566.23152889.46109863.08115459.85106739.01
最后修改日期2026-10-292026-08-242026-04-282026-03-282025-11-01
↑返回页顶↑

转至荣昌生物（688331）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。